Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Treatment for female hyposexual desire disorder edges closer

Palatin Technologies has applied to the US Food and Drug Administration for marketing approval for melanocortin-receptor-4 agonist bremelanotide for the...Read more

Europe agrees measures to stop valproate use during pregnancy

European states are set to ban valproate for treating migraine or bipolar disorder and to limit its use to treat epilepsy as a last resort. Women or girls of...Read more

Developments in treatments for MS

Roche’s monoclonal antibody ocrelizumab (Ocrevus) has become the first medicine licensed for the treatment of primary progressive multiple sclerosis (PPMS)...Read more

Adjunctive treatment fails to help Alzheimer’s disease

The 5-hydroxytryptamine-6 receptor antagonist idalopirdine did not improve cognition in people with mild to moderate Alzheimer’s disease when added to...Read more

Government consults on children’s mental health

The Government published proposals to improve mental health support for children and young people at the beginning of December 2017. Its Green Paper,...Read more

Featured Articles

Neurological sleep medicine: a case note audit from a specialist clinic
In this article, the authors report the findings of an audit of patients with neurological sleep disorders seen in a combined cognitive neurology and sleep disorder clinics over a seven-year period. Also, the results of a pilot of a cognitive behavioural therapy service for insomnia undertaken in the same population are analysed. 
Click here to view

Episodic loss of consciousness: how genetic testing points to diagnosis
The differential diagnosis of episodic loss of consciousness, lying chiefly between syncope and epilepsy, can be challenging and potentially confusing, particularly in the absence of a reliable witness account. We report a patient with episodic loss of consciousness in whom targeted genetic testing contributed to diagnosis. 
Click here to view

‘Z’-hypnotics versus benzodiazepines for the treatment of insomnia
Z-hypnotics have been perceived to be better than benzodiazepines for the treatment of insomnia for many years. NICE guidance focuses on cost effectiveness as there is limited convincing evidence to distinguish between these agents. This review compares Z-drugs and benzodiazepines as hypnotic agents in terms of their efficacy, safety, tolerability and abuse potential.
Click here to view

Web design and marketing agency Leamington Spa